Free/total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical prostatectomy
- 1 February 2002
- Vol. 59 (2) , 256-260
- https://doi.org/10.1016/s0090-4295(01)01515-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and stagingUrology, 2000
- PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOINGJournal of Urology, 1999
- The free‐to‐total serum prostatic specific antigen ratio as a predictor of the pathological features of prostate cancerBJU International, 1999
- NONPALPABLE STAGE T1C PROSTATE CANCER: PREDICTION OF INSIGNIFICANT DISEASE USING FREE/TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS AND NEEDLE BIOPSY FINDINGSJournal of Urology, 1998
- PROSTATE SPECIFIC ANTIGEN DENSITY OF THE TRANSITION ZONE FOR PREDICTING PATHOLOGICAL STAGE OF LOCALIZED PROSTATE CANCER IN PATIENTS WITH SERUM PROSTATE SPECIFIC ANTIGEN LESS THAN 10 NG./ML.Journal of Urology, 1998
- Serum Percent–Free PSA Does Not Predict Extraprostatic Spread of Prostate CancerAmerican Journal of Clinical Pathology, 1998
- The Free-to-Total Serum Prostate Specific Antigen Ratio for Staging Prostate CarcinomaJournal of Urology, 1997
- Free-to-Total Prostate Specific Antigen Ratio as a Single Test for Detection of Significant Stage T1c Prostate CancerJournal of Urology, 1996
- Free, complexed and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostateUrology, 1996
- Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancerThe Prostate, 1996